Sales of Gilead's Truvada pill against HIV aren't getting a boost from data that show it can prevent infection.
February 28, 2011 Sales of a drug to treat HIV haven't showed a big increase since a study showed it could also prevent infection. An annual cost around $13,000 could be one reason.
December 1, 2010 Today's a day to pause, reflect and read up on the disease that remains a critical problem around the globe.
<iframe src="http://www.npr.org/player/embed/131722223/131722347" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
August 4, 2008 What innovative, effective programs to fight HIV/AIDS are working where you live? ...
NPR thanks our sponsors
Become an NPR sponsor